A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder

Clinical trial NCT01340027 · COMPLETED

Trial details

NCT number: NCT01340027
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Urologic Diseases Urinary Bladder Diseases Urological Manifestations Signs and Symptoms Urinary Bladder, Overactive

Start date: 2011-03-29
Primary completion: 2012-06-28
Enrollment: 1307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.